Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 332

1.

A Child With Pancytopenia and Optic Disc Swelling.

Berk J, Hall D, Stroh I, Armstrong C, Mishra K, Pecker LH, Lau BW.

Pediatrics. 2019 Oct 8. pii: e20182887. doi: 10.1542/peds.2018-2887. [Epub ahead of print]

PMID:
31594907
2.

Effects of Elevated Grids on Growing Male Chickens Differing in Growth Performance.

Malchow J, Puppe B, Berk J, Schrader L.

Front Vet Sci. 2019 Jun 25;6:203. doi: 10.3389/fvets.2019.00203. eCollection 2019.

3.

Defining Palliative Care Needs in Parkinson's Disease.

Kluger BM, Shattuck J, Berk J, Sebring K, Jones W, Brunetti F, Fairmont I, Bowles DW, Sillau S, Bekelman DB.

Mov Disord Clin Pract. 2018 Nov 16;6(2):125-131. doi: 10.1002/mdc3.12702. eCollection 2019 Feb.

PMID:
30838311
4.

Perches or grids? What do rearing chickens differing in growth performance prefer for roosting?

Malchow J, Berk J, Puppe B, Schrader L.

Poult Sci. 2019 Jan 1;98(1):29-38. doi: 10.3382/ps/pey320.

PMID:
30690612
5.

Novel first-year curriculum in high-value care.

Steele C, Cayea D, Berk J, Riddell R, Kumra T, McGuire M, Pahwa AK.

Clin Teach. 2019 Oct;16(5):513-518. doi: 10.1111/tct.12989. Epub 2019 Jan 15.

PMID:
30644162
6.

TTR Gene Silencers for Hereditary ATTR Amyloidosis: More than ICER Recognized.

Berk JL.

J Manag Care Spec Pharm. 2019 Jan;25(1):15-16. doi: 10.18553/jmcp.2019.25.1.015.

7.

Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis.

Solomon SD, Adams D, Kristen A, Grogan M, González-Duarte A, Maurer MS, Merlini G, Damy T, Slama MS, Brannagan TH 3rd, Dispenzieri A, Berk JL, Shah AM, Garg P, Vaishnaw A, Karsten V, Chen J, Gollob J, Vest J, Suhr O.

Circulation. 2019 Jan 22;139(4):431-443. doi: 10.1161/CIRCULATIONAHA.118.035831.

PMID:
30586695
8.

Cholesterol increases protein levels of the E3 ligase MARCH6 and thereby stimulates protein degradation.

Sharpe LJ, Howe V, Scott NA, Luu W, Phan L, Berk JM, Hochstrasser M, Brown AJ.

J Biol Chem. 2019 Feb 15;294(7):2436-2448. doi: 10.1074/jbc.RA118.005069. Epub 2018 Dec 13.

PMID:
30545937
9.

The Basement Flight

Pande CK, Berk J, Jassal MS, Manesh R, Olson AP.

J Hosp Med. 2019 Jan 8;14(1):51-55. doi: 10.12788/jhm.3096. Epub 2018 Nov 28.

PMID:
30534638
10.

Investigation of the prevalence and severity of foot pad dermatitis at the slaughterhouse in fattening turkeys reared in organic production systems in Germany.

Freihold D, Bartels T, Bergmann S, Berk J, Deerberg F, Dressel A, Erhard MH, Ermakow O, Huchler M, Krautwald-Junghanns ME, Spindler B, Thieme S, Hafez HM.

Poult Sci. 2019 Apr 1;98(4):1559-1567. doi: 10.3382/ps/pey473.

PMID:
30496524
11.

Oligonucleotide Drugs for Transthyretin Amyloidosis.

Berk JL, Barroso FA, Coelho T.

N Engl J Med. 2018 Nov 22;379(21):2085-6. doi: 10.1056/NEJMc1810994. No abstract available.

PMID:
30484623
12.

A Cross-sectional Survey Using Clinical Vignettes to Examine Overdose Risk Assessment and Willingness to Prescribe Naloxone.

Deanna Wilson J, Berk J, Matson P, Spicyn N, Alvanzo A, Adger H, Feldman L.

J Gen Intern Med. 2019 Apr;34(4):507-509. doi: 10.1007/s11606-018-4733-y. No abstract available.

PMID:
30406568
13.

Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial.

Waddington-Cruz M, Ackermann EJ, Polydefkis M, Heitner SB, Dyck PJ, Barroso FA, Wang AK, Berk JL, Dyck PJB, Monia BP, Hughes SG, Tai L, Jesse Kwoh T, Jung SW, Coelho T, Benson MD, Gertz MA.

Amyloid. 2018 Sep;25(3):180-188. doi: 10.1080/13506129.2018.1503593. Epub 2018 Aug 31.

PMID:
30169969
14.

Identifying Missed Clinical Opportunities in Delivery of Overdose Prevention and Naloxone Prescription to Adolescents Using Opioids.

Wilson JD, Berk J, Adger H, Feldman L.

J Adolesc Health. 2018 Aug;63(2):245-248. doi: 10.1016/j.jadohealth.2018.05.011.

15.

RD or Not RD: Using Experimental Studies to Assess the Performance of the Regression Discontinuity Approach.

Gleason P, Resch A, Berk J.

Eval Rev. 2018 Feb;42(1):3-33. doi: 10.1177/0193841X18787267. Epub 2018 Aug 20.

PMID:
30126296
16.

A library of ATTR amyloidosis patient-specific induced pluripotent stem cells for disease modelling and in vitro testing of novel therapeutics.

Giadone RM, Rosarda JD, Akepati PR, Thomas AC, Boldbaatar B, James MF, Wilson AA, Sanchorawala V, Connors LH, Berk JL, Wiseman RL, Murphy GJ.

Amyloid. 2018 Sep;25(3):148-155. doi: 10.1080/13506129.2018.1489228. Epub 2018 Jul 21.

17.

Assessing the validity of proxy caregiver reporting for potential palliative care outcome measures in Parkinson's disease.

Sebring K, Shattuck J, Berk J, Boersma I, Sillau S, Kluger BM.

Palliat Med. 2018 Oct;32(9):1522-1528. doi: 10.1177/0269216318785830. Epub 2018 Jul 17.

PMID:
30015552
18.

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis.

Benson MD, Waddington-Cruz M, Berk JL, Polydefkis M, Dyck PJ, Wang AK, Planté-Bordeneuve V, Barroso FA, Merlini G, Obici L, Scheinberg M, Brannagan TH 3rd, Litchy WJ, Whelan C, Drachman BM, Adams D, Heitner SB, Conceição I, Schmidt HH, Vita G, Campistol JM, Gamez J, Gorevic PD, Gane E, Shah AM, Solomon SD, Monia BP, Hughes SG, Kwoh TJ, McEvoy BW, Jung SW, Baker BF, Ackermann EJ, Gertz MA, Coelho T.

N Engl J Med. 2018 Jul 5;379(1):22-31. doi: 10.1056/NEJMoa1716793.

19.

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.

Adams D, Gonzalez-Duarte A, O'Riordan WD, Yang CC, Ueda M, Kristen AV, Tournev I, Schmidt HH, Coelho T, Berk JL, Lin KP, Vita G, Attarian S, Planté-Bordeneuve V, Mezei MM, Campistol JM, Buades J, Brannagan TH 3rd, Kim BJ, Oh J, Parman Y, Sekijima Y, Hawkins PN, Solomon SD, Polydefkis M, Dyck PJ, Gandhi PJ, Goyal S, Chen J, Strahs AL, Nochur SV, Sweetser MT, Garg PP, Vaishnaw AK, Gollob JA, Suhr OB.

N Engl J Med. 2018 Jul 5;379(1):11-21. doi: 10.1056/NEJMoa1716153.

20.

Unusual duplication mutation in a surface loop of human transthyretin leads to an aggressive drug-resistant amyloid disease.

Klimtchuk ES, Prokaeva T, Frame NM, Abdullahi HA, Spencer B, Dasari S, Cui H, Berk JL, Kurtin PJ, Connors LH, Gursky O.

Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):E6428-E6436. doi: 10.1073/pnas.1802977115. Epub 2018 Jun 25.

21.

Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience.

Mints YY, Doros G, Berk JL, Connors LH, Ruberg FL.

ESC Heart Fail. 2018 Oct;5(5):772-779. doi: 10.1002/ehf2.12308. Epub 2018 Jun 19.

22.

External beam radiation for localized periocular amyloidosis: a case series.

Copperman TS, Truong MT, Berk JL, Sobel RK.

Orbit. 2019 Jun;38(3):210-216. doi: 10.1080/01676830.2018.1483407. Epub 2018 Jun 11.

PMID:
29889595
23.

Once AL amyloidosis: not always AL amyloidosis.

Jhaveri T, Sarosiek S, Ruberg FL, Siddiqi O, Berk JL, Sanchorawala V.

Amyloid. 2018 Jun;25(2):139-140. doi: 10.1080/13506129.2018.1449104. Epub 2018 Mar 8. No abstract available.

PMID:
29516761
24.

Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin.

Hanson JLS, Arvanitis M, Koch CM, Berk JL, Ruberg FL, Prokaeva T, Connors LH.

Circ Heart Fail. 2018 Feb;11(2):e004000. doi: 10.1161/CIRCHEARTFAILURE.117.004000.

25.

Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR).

Phull P, Sanchorawala V, Connors LH, Doros G, Ruberg FL, Berk JL, Sarosiek S.

Amyloid. 2018 Mar;25(1):62-67. doi: 10.1080/13506129.2018.1436048. Epub 2018 Feb 9.

26.

Implementation issues relevant to outpatient neurology palliative care.

Kluger BM, Persenaire MJ, Holden SK, Palmer LT, Redwine H, Berk J, Anderson CA, Filley CM, Kutner J, Miyasaki J, Carter J.

Ann Palliat Med. 2018 Jul;7(3):339-348. doi: 10.21037/apm.2017.10.06. Epub 2017 Nov 29.

27.

UV reflection properties of plumage and skin of domesticated turkeys (Meleagris gallopavo f. dom.) as revealed by UV photography.

Bartels T, Lütgeharm JH, Wähner M, Berk J.

Poult Sci. 2017 Dec 1;96(12):4134-4139. doi: 10.3382/ps/pex256.

PMID:
29053857
28.

Prevalence of mutant ATTR cardiac amyloidosis in elderly African Americans with heart failure.

Arvanitis M, Chan GG, Jacobson DR, Berk JL, Connors LH, Ruberg FL.

Amyloid. 2017 Dec;24(4):253-255. doi: 10.1080/13506129.2017.1391086. Epub 2017 Oct 20. No abstract available.

29.

Medical students' perceptions of low-value care.

Steele C, Berk J, Ashar B, Pahwa A, Cayea D.

Clin Teach. 2018 Oct;15(5):408-412. doi: 10.1111/tct.12705. Epub 2017 Oct 3.

PMID:
28971621
30.

Peptide probes detect misfolded transthyretin oligomers in plasma of hereditary amyloidosis patients.

Schonhoft JD, Monteiro C, Plate L, Eisele YS, Kelly JM, Boland D, Parker CG, Cravatt BF, Teruya S, Helmke S, Maurer M, Berk J, Sekijima Y, Novais M, Coelho T, Powers ET, Kelly JW.

Sci Transl Med. 2017 Sep 13;9(407). pii: eaam7621. doi: 10.1126/scitranslmed.aam7621.

31.

Artificial neural network modelling of ATTR amyloidosis: is now the time?

Berk JL.

Amyloid. 2017 Sep;24(3):141-142. doi: 10.1080/13506129.2017.1345732. Epub 2017 Jul 18. No abstract available.

PMID:
28719235
32.

Retinol binding protein 4 (RBP4) concentration identifies V122I transthyretin cardiac amyloidosis.

Arvanitis M, Simon S, Chan G, Fine D, Beardsley P, LaValley M, Jacobson D, Koch C, Berk JL, Connors LH, Ruberg FL.

Amyloid. 2017 Mar;24(sup1):120-121. doi: 10.1080/13506129.2017.1295371. No abstract available.

33.

Familial wild-type transthyretin cardiomyopathy.

Benson MD, Berk JL, Connors LH, Dasgupta NR.

Amyloid. 2017 Mar;24(sup1):91-92. doi: 10.1080/13506129.2017.1281118. No abstract available.

PMID:
28434303
34.

Transbronchial biopsies safely diagnose amyloid lung disease.

Govender P, Keyes CM, Hankinson EA, O'Hara CJ, Sanchorawala V, Berk JL.

Amyloid. 2017 Mar;24(1):37-41. doi: 10.1080/13506129.2017.1301917. Epub 2017 Apr 10.

35.

The six-minute walk test in patients with AL amyloidosis: a single centre case series.

Pulido V, Doros G, Berk JL, Sanchorawala V.

Br J Haematol. 2017 May;177(3):388-394. doi: 10.1111/bjh.14586. Epub 2017 Mar 24.

PMID:
28340285
36.

Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.

Arvanitis M, Koch CM, Chan GG, Torres-Arancivia C, LaValley MP, Jacobson DR, Berk JL, Connors LH, Ruberg FL.

JAMA Cardiol. 2017 Mar 1;2(3):305-313. doi: 10.1001/jamacardio.2016.5864.

37.

Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial.

Dyck PJ, Kincaid JC, Dyck PJB, Chaudhry V, Goyal NA, Alves C, Salhi H, Wiesman JF, Labeyrie C, Robinson-Papp J, Cardoso M, Laura M, Ruzhansky K, Cortese A, Brannagan TH 3rd, Khoury J, Khella S, Waddington-Cruz M, Ferreira J, Wang AK, Pinto MV, Ayache SS, Benson MD, Berk JL, Coelho T, Polydefkis M, Gorevic P, Adams DH, Plante-Bordeneuve V, Whelan C, Merlini G, Heitner S, Drachman BM, Conceição I, Klein CJ, Gertz MA, Ackermann EJ, Hughes SG, Mauermann ML, Bergemann R, Lodermeier KA, Davies JL, Carter RE, Litchy WJ.

Muscle Nerve. 2017 Nov;56(5):901-911. doi: 10.1002/mus.25563. Epub 2017 Apr 7.

38.

Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis.

Salinaro F, Meier-Ewert HK, Miller EJ, Pandey S, Sanchorawala V, Berk JL, Seldin DC, Ruberg FL.

Eur Heart J Cardiovasc Imaging. 2017 Sep 1;18(9):1057-1064. doi: 10.1093/ehjci/jew298.

PMID:
27965280
39.

Depression and anxiety in patients with AL amyloidosis as assessed by the SF-36 questionnaire: experience in 1226 patients.

Shu J, Lo S, Phillips M, Sun F, Seldin DC, Berenbaum I, Berk JL, Sanchorawala V.

Amyloid. 2016 Sep;23(3):188-193. Epub 2016 Jul 27.

PMID:
27460276
40.

Can 99mTc-Pyrophosphate Aid in Early Detection of Cardiac Involvement in Asymptomatic Variant TTR Amyloidosis?

Haq M, Pawar S, Berk JL, Miller EJ, Ruberg FL.

JACC Cardiovasc Imaging. 2017 Jun;10(6):713-714. doi: 10.1016/j.jcmg.2016.06.003. Epub 2016 Aug 24. No abstract available.

41.

Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.

Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, Pozniakoff T, Ruberg FL, Miller EJ, Berk JL, Dispenzieri A, Grogan M, Johnson G, Bokhari S, Maurer MS.

JAMA Cardiol. 2016 Nov 1;1(8):880-889. doi: 10.1001/jamacardio.2016.2839.

PMID:
27557400
42.

Protein Modification: Bacterial Effectors Rewrite the Rules of Ubiquitylation.

Berk JM, Hochstrasser M.

Curr Biol. 2016 Jul 11;26(13):R539-R542. doi: 10.1016/j.cub.2016.05.032.

43.

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Guidalotti PL, Flatman K, Lane T, Vonberg FW, Whelan CJ, Moon JC, Ruberg FL, Miller EJ, Hutt DF, Hazenberg BP, Rapezzi C, Hawkins PN.

Circulation. 2016 Jun 14;133(24):2404-12. doi: 10.1161/CIRCULATIONAHA.116.021612. Epub 2016 Apr 22.

PMID:
27143678
44.

A Conserved C-terminal Element in the Yeast Doa10 and Human MARCH6 Ubiquitin Ligases Required for Selective Substrate Degradation.

Zattas D, Berk JM, Kreft SG, Hochstrasser M.

J Biol Chem. 2016 Jun 3;291(23):12105-18. doi: 10.1074/jbc.M116.726877. Epub 2016 Apr 11.

45.

Randomized, Controlled Trial of Acupuncture for Fatigue in Parkinson's Disease.

Kluger BM, Rakowski D, Christian M, Cedar D, Wong B, Crawford J, Uveges K, Berk J, Abaca E, Corbin L, Garvan C.

Mov Disord. 2016 Jul;31(7):1027-32. doi: 10.1002/mds.26597. Epub 2016 Mar 29.

PMID:
27028133
46.

Simple Separation of Functionally Distinct Populations of Lamin-Binding Proteins.

Berk JM, Wilson KL.

Methods Enzymol. 2016;569:101-14. doi: 10.1016/bs.mie.2015.09.034. Epub 2015 Oct 27.

PMID:
26778555
47.

Electrical resistance increases at the tissue-electrode interface as an early response to nucleus accumbens deep brain stimulation.

Kale RP, Kouzani AZ, Berk J, Walder K, Berk M, Tye SJ.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:1814-1817. doi: 10.1109/EMBC.2016.7591071.

PMID:
28324953
48.

Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin: A Prospective, Observational Cohort Study.

Connors LH, Sam F, Skinner M, Salinaro F, Sun F, Ruberg FL, Berk JL, Seldin DC.

Circulation. 2016 Jan 19;133(3):282-90. doi: 10.1161/CIRCULATIONAHA.115.018852. Epub 2015 Dec 11.

49.

Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis.

Gertz MA, Benson MD, Dyck PJ, Grogan M, Coelho T, Cruz M, Berk JL, Plante-Bordeneuve V, Schmidt HHJ, Merlini G.

J Am Coll Cardiol. 2015 Dec 1;66(21):2451-2466. doi: 10.1016/j.jacc.2015.09.075. Review.

50.

Clinical presentation and treatment responses in IgM-related AL amyloidosis.

Sissoko M, Sanchorawala V, Seldin D, Sworder B, Angelino K, Broce M, Berk J, Sloan JM.

Amyloid. 2015;22(4):229-35. doi: 10.3109/13506129.2015.1092433. Epub 2015 Oct 21.

PMID:
26488936

Supplemental Content

Support Center